You cannot model the IFR accurately from skewed samples and it feels like we aren't even doing skewed sampling.
You cannot model the IFR accurately from skewed samples and it feels like we aren't even doing skewed sampling.
Testing resources are in short supply, so testing is being performed to guide clinical decisions (ie sick people) rather than public health/science (ie random sample).
The handful of serosurveys that have been performed have been quite valuable, but there aren't nearly enough.
Hopefully this changes as testing capacity ramps up.
There are a million reason for differences like that, without studying the problem extremely carefully, you'll never know which of those reasons was consequential. For instance, more people may die in a certain city because there is more pollution in the air, or the concentration of fluoride in the city's water supply is higher, or maybe that city houses a large meat packing plant and an abnormally large number of residents had to roll the dice and work throughout the lockdown. The number of possibilities are nearly endless, and you'd need to eliminate them prior to drawing any conclusions.
Even ethnically, you can't really draw any conclusions. Were people of this ethnicity or that ethnicity more likely to be essential Walmart stockboys than others? That one little detail can have an enormous impact on medical outcomes depending on the contagiousness of a pathogen like covid-19.
To draw any reasonable conclusions, you'd really need far more than just a comparison between regions, because the different regions have such different public health needs and environmental realities. You'd even need more than a simple comparison between ethnicities. You would need to go wayyy more deep. But I can guarantee that researchers will dig deep to find anything that can be used attack similar pathogens in the future.
It seems likely to me that this problem will get studied extremely carefully.
Fits in Italy, as their elderly are retired locals exposed to their terrible air for life. In China, the hard hit had a transient population that moves away on retirement. In New York, it is hitting more men, who are proportionally more likely to with outside jobs such as construction. That is to say, all of the hard hit groups had long term exposure to pollution.
And again I stress. I view this as my conspiracy theory. Really want to not believe it.
On a lower, slower timeframe I wouldn't be surprised if pollution had the same effect re: weakening the lungs.
apparently, the number of people receiving hospital treatment or dying from yearly virus infections like the flu has dropped significantly.
The issue is that many samples do not contain virus. As far as I know, that has not been quantified outside of China. (2)
1. https://www.fda.gov/media/136151/download
2. https://www.mdmag.com/medical-news/comparing-rt-pcr-and-ches...
The PCR test itself has near 100% sensitivity and specificity when done correctly.
Poor swabbing or contamination can result in false negatives or positives.
Manual PCR testing is known to be quite prone to human errors hence why the all in one cassette kits are quite popular.
- Policy makers weighing the strategic pros/cons to orders for the public
- Individuals (either frightened or skeptical) weighing their decisions
- Physicians treating patients
- Quarantining people based on contact tracing
There are ways of doing population wide testing that are not very invasive.
If policy had been informed, the number of people saved would have out-weighed the handful who died due to missing out on a test.
Several orders of magnitude more people have been killed by uninformed policy than would have been killed by redirecting a portion of tests. What kind of MONSTER chooses for so many more people to die?!?
What would change in public policy with more randomized tests?
By comparison many ill people are currently being told to stay home until they have difficulty breathing, making tests have minimal clinical value. Especially as the risk of false negatives are significant.
* PCR tests to check if you are carrier of the virus right now. That's what you do with patients and personnel.
* Anti-body tests to gauge the number of people having been exposed to the virus in the past.
It takes a couple of days to develop anti-bodies so you don't want to use that one for the first use-case. And you can have anti-bodies without carrying the virus. (Well, it depends on the type of antibodies)
If you know the exposure in the general public, we would better know the real mortality, how far we are with herd-immunity, and if general quarantines do make sense, or it might be sensible to be more selective.
Randomized tests would have told policy makes exactly how fast this spreads, even in Western cities. Lockdowns would have happened earlier. The total number of infected would be 1-2 orders of magnitude lower. Hospitals would have been better off.
>Would you want one of your loved ones in that position?
I wouldn't want one of my loved ones to die because my civilization was so short-sighted that it let a disease run rampant. Your appeal to emotion is garbage, and it doesn't even make sense, since all of our chances would be better if we'd known what was going on.
- SARS started out with a similar <4% estimated fatality rate and was then revised upwards to anywhere from 9-15% later.
- COVID-19 is caused by a different strain of the same virus as SARS.
- The CFR of SARS and COVID-19 appear to be very similar, and more notably, appeared by be very similar when we had around 8,000 infections which is where SARS ended. (Similar meaning the CFR hovers between 4% and 20% of closed cases.)
How are we so sure that this is any less deadly than SARS?
The above suggests to me one of the two is likely to be true:
1. There could have been many more undetected cases of SARS than we knew about, indicting an IFR much lower than it's recorded CFR.
2. COVID-19 could actually end up having an IFR that is similar to SARS (~10%).
But of course, I am no epidemiologist, so I assume there's a flaw in my logic.
Did I miss something, or is this pretty much the same disease as SARS but with a higher R0?
Studies on COVID-19 estimate that the true IFR is somewhere between 0.1% to 0.39%...why? Because the more we test, the more we find asymptomatic and mild cases. And we're yet to even do the type of serological testing that would give us such a decisive sample. Yet we're ALREADY seeing data that suggests that the IFR is lower than SARS and asymptomatic cases/transmission are common. [0]
I never read anything about SARS being mild or asymptomatic in the majority of patients...in fact it was the opposite. It was so severely symptomatic that the virus killed itself with natural selection. If you had SARS-COV-11 and exhibited high viral load, you were likely too sick to go spread it. The only serological testing they did on SARS-COV-1 deemed asymptomatic cases to be uncommon [1]. Quite the opposite of COVID-19.
0: https://www.cebm.net/covid-19/global-covid-19-case-fatality-...
In two closed environments where everyone was tested, the Diamond Princess and the Washington Choir, the CFR is currently 1.55% and 4.44% respectively, with still cases in critical condition.
Of courses both populations are older, but it seems safe to say that the IFR is much higher than the numbers you quoted for older populations.
However, given the high R0 and still somewhat high IFR for older populations and even a relatively high IFR compared with the flu IFR for younger populations this virus still has the potential to wreak havoc.
What we are seeing is that a disease with a high R0 can be much more deadly than a disease with a lower R0 and higher IFR.
Meanwhile, your link in [0] flat-out says we don't know the percent of asymptomatic cases. It is well-documented they exist. I have also seen some papers estimating the percent of cases that are asymptomatic as well under 20%, and as high as the 80-90% range, the difference between them making an enormous difference to the implied mortality rate.
A month ago, people pointed to South Korea's 0.5% fatality rate, a country which tests very aggressively, as an indication that the true fatality rate is much lower. Well, they still test just as aggressively, and now their mortality rate has risen to 1.96%. The disease started spreading in a population that skewed young there, and but now the disease has started to hit older demographics who have a much higher mortality rate. And of course, "asymptomatic" cases can also mean pre-symptomatic cases, as happened with the Diamond Princess, which had an observed 46% of positive cases be asymptomatic...only to have this rate fall to ~17% later.
4500/1112187
https://translate.google.com/translate?hl=en&sl=it&u=https:/....
https://en.wikipedia.org/wiki/Province_of_Bergamo
EDIT: and there are harder hit communities: 400/40000 https://www.ecodibergamo.it/stories/valle-brembana/il-grido-...
Yes, SARS-1 and SARS-2 (Covid-19) are more similar than not. But debating IFR, CFR or R0 with the testing data we have is pointless.
You can learn a lot about the nature of SARS-1 by reading about the 2002 warzone in Toronto hospitals, which wiped out whole ICU teams. Sounds just like corona today in Italy or NY.
Using old data that misses fully half of the deaths so far... (and there are still people in serious condition).
For SARS resolved CFR was a more accurate estimator at all points in time: https://academic.oup.com/aje/article/162/5/479/82647
The final R0 is I guess is how all those values average out in a society. Is it normal for all the different societies around the planet to have the same values?
R0 is dependent on parameters taken into consideration and the model itself. R0 makes sense only in the context laid out by the model.
> An R0 of kids crawling over each other in a kindergarten must be different to an retired estate where most people spend their time in their own house.
Ref: https://news.ycombinator.com/item?id=22818413
> The final R0 is I guess is how all those values average out in a society.
See: https://en.m.wikipedia.org/wiki/Basic_reproduction_number#No...
Preliminary results and conclusions of the COVID-19 Case Cluster Study (Gangelt municipality)
Prof. Dr. Hendrik Streeck (Institute for Virology)
Prof. Dr. Gunther Hartmann (Institute for Clinical Chemistry and Clinical Pharmacology, Speaker of the Cluster of Excellence ImmunoSensation2)
Prof. Dr. Martin Exner (Institute for Hygiene and Public Health)
Prof. Dr. Matthias Schmid (Institute for Medical Biometry, Informatics and Epidemiology)
University Hospital Bonn, Bonn, 9 April 2020
Background: The municipality of Gangelt is one of the places in Germany most affected by COVID19 . It is assumed that the infection is due to a carnival session on 15 February 2020, as several people tested positive for SARSCoV2 in the aftermath of this session. The carnival session and the outbreak of the session are currently being investigated in more detail. A representative sample was taken from the community
Gangelt (12,529 inhabitants) in the Heinsberg district. The World Health Organization (WHO) recommends a protocol in which, depending on the expected prevalence, 100 to 300 households are randomly examined. This random sample was coordinated with Prof. Manfred Güllner (Forsa) to ensure its representativeness.
Aim: The aim of the study is to determine the status of SARS-CoV2 infections (percentage of all infected persons) in the community of Gangelt, which have been and are still occurring. In addition, the status of the current SARS-CoV2 immunity shall be determined.
Procedure: A serial letter was sent to about 600 households. In total, about 1000 inhabitants from about 400 households took part in the study. Questionnaires were collected, throat swabs taken and blood tested for the presence of antibodies (IgG, IgA). The interim results and conclusions of approx. 500 persons are included in this first evaluation.
Preliminary result: An existing immunity of approx. 14% (antiSARS-CoV2 IgG positive, specificity of the method >.99 %) was determined. About 2% of the persons had a current SARS-CoV-2 infection detected by PCR method. The infection rate (current infection or already been through) was about 15 % in total. The case fatality rate in relation to the total number of infected persons in the community of Gangelt is approx. 0.37 % with the preliminary data from this study. The lethality rate currently calculated in Germany by Johns-Hopkins University is 1.98 %, which is 5 times higher. The mortality in relation to the total population in Gangelt is currently 0.15 %.
Preliminary conclusion: The lethality calculated by Johns-Hopkins University is 5 times higher than in this study in Gangelt, which is explained by the different reference size of the infected persons. In Gangelt, this study covers all infected persons in the sample, including those with asymptomatic and mild courses. In Gangelt, the proportion of the population that has already developed immunity to SARS-CoV-2 is about 15%. This means that 15% of the population in Gangelt can no longer become infected with SARS-CoV-2, and the process has already begun until herd immunity is achieved. This 15% of the population reduces the speed (net reproduction rate R in epidemiological models) of a further spread of SARS-CoV-2 accordingly.
By adhering to strict hygiene measures, it can be expected that the virus concentration in a person infected can be reduced to such an extent that the severity of the disease is reduced, while at the same time immunity is developed. These favourable conditions are not given in the case of an exceptional outbreak event (superspreading event, e.g. carnival session, après-ski bar Ischgl). With hygiene measures, favourable effects with regard to total mortality can be expected.
We therefore expressly recommend implementing the proposed four-phase strategy of the German Society for Hospital Hygiene (DGKH). This strategy provides for the following model:
Phase 1: Social quarantine with the aim of containing and slowing down the pandemic and avoiding overloading critical supply structures, especially the Health care system
Phase 2: Beginning of the withdrawal of quarantine while ensuring hygienic conditions and behaviour.
Phase 3: Lifting of the quarantine while maintaining the hygienic conditions
Phase 4: State of public life as before the COVID-19 pandemic (status quo ante).
(Statement of the DGKH can be found here:
https://www.krankenhaushygiene.de/ccUpload/upload/files/2020... adug_Lageeinschaetzung.pdf)
Note: These results are preliminary. The final results of the study will be published and presented to the public as soon as they are available.
This is the most interesting part of this and should be discussed more. There seems to be a lot of evidence that viral load is a factor. If social distancing and proper hygiene doesn't just lead to less infections but to more mild infections that's a big dea.
(Source: lecture by prof. Krzysztof Pyrć)
Seems to me like Santa Clara was just testing sink people to me
At the time the investigation began, testing guidance recommended focusing on persons with clinical findings of lower respiratory illness and travel to an affected area or an epidemiologic link to a laboratory-confirmed COVID-19 case, or on persons hospitalized for severe respiratory disease and no alternative diagnosis (1).
At the time, the standard was to test people with travel history to affected areas or when they were hospitalized for unexplained respiratory illness.
Compare that to testing people that went to urgent care because they felt sick. There's a difference.
Santa Clara's results are basically only useful for Santa Clara. _Maybe_ the Bay Area in addition, but not really any farther.
So, we DO need surveillance testing, on a much wider scale, across the US and globally to be frank.
That's super useful information when most testing is using restrictive criteria like travel to affected areas.
They aren't arguing that it was enough, they are pointing at it as an example of what broader testing can help do, if only it existed.
So I don't really understand your refutational tone ("Still", "relevant", "only useful", "DO", etc). Is one of us misunderstanding the flow of the thread?
on the similar lines, Germany is doing something clever, they are mixing samples to do a kind of binary search with covid tests so they can clear a large number of people with few tests. we should do that without waiting for antibody tests etc. it should be noted that this approach would only work if the infected sample set is very small so the window of doing this is going to close soon.
What actions would we do differently based on the result? Not knowing is frustrating for everyone, but we should save our resources for stuff that's actually going to improve outcomes.
as you can see both of these scenarios have different optimal responses but we cannot decide unless we get this info. so far we only have a few biased sample sets (from us pov) diamond cruise & skorea which dont shed much light on our situation.
1) to guide care in a hospital setting. 2) to determine the current status of the population.
Randomized testing would give us a view into where the virus is spreading and allow us to allocate resources effectively. It would also give us a view into what percentage of a given population is a carrier, or has already recovered. All of these data would be greatly helpful. What isn’t helpful is using tests on people who aren’t either part of a study or under active care.
If the IFR is 1/10th (quite possible!) or 1/50th (less likely, but still possible) of the current estimate, it completely changes the calculus for locking things down. A fifty fold under-estimate of infections would mean that approximately half of NYC has already been infected, for example, and that we're not far from herd immunity.
We just don't know.
Do you have a link for that? I can find some papers suggesting you can detect one positive sample mixed with 31 negative, but nothing about that being applied.
"Testing capacity in Germany will be increased by up to factor 10 to up to 400,000 a day (!) by doing pooled testing. E.g mix 16 samples and if negative - all are negative, otherwise binary search for the positive(s). Could of course be used worldwide."
He quotes a tweet with a link to this study: https://idw-online.de/de/news743899
https://grapevine.is/news/2020/04/06/random-sampling-reveals...
This is a useful albeit very small data point, because Iceland received its cases from both Europe (alpine ski cluster) and the US. So it puts a very loose upper bound on the incidence in the US up to the point travel to Iceland was effectively halted.
(My apologies for not citing the article, I had read it in the paper edition of the NY Times, and failed to find it online.)
If so, here is a related article about how they tested everyone there: https://www.theguardian.com/world/2020/mar/18/scientists-say...
Edit: I rechecked, the numbers are right but apparently this has been the first test. It hasn't passed enought time to see if those that tested positive, but were asymptomatic, later on develop symptoms.
It would possibly help planning for the next phase. But mostly it would feed our curiosity.
Contrast to using limited tests to find the greatest number of infected people: every additional person knowing without a doubt that they are infected is one more person doing their best not to spread it further.
It’s wasteful to test randomly until we are able to test high risk groups every day or so. Cashiers, for example are at high risk of infection, and ha e possibly hundreds of contacts per day.
For population-randomized testing, antibody tests should be far superior anyway. They allow detection of. It just active cases but also past infections.
[0]: https://www.sciencedaily.com/releases/2020/03/200331092713.h...
So then the question is, do you go out into the general population with law enforcement, and force people who were drawn in the testing lotto to be tested at gunpoint if they don't comply? I think the answer is that we don't have the will to do that. And perhaps even if this would be incredibly valuable data, it would be morally wrong to gather it in the way we'd have to gather it to have a truly random sample without such a confounding variable.
I am not a doctor, not an epidemiologist. Just some random thoughts.
If looking to go beyond, hey let's get testing capacity to the point where those who are sick and desperately want to be tested can be tested, then we can attack the 1984 fantasy.
"But but what if I can't force those to be tested who don't want it" is an absurd and insane concern given that only a tiny minority of people can be tested who desperately want to.
Once we have testing capacity then those who want to force testing should go out and try to force people to be tested and happily accept whatever happens to them.
1. I’m all for more testing, and would gladly be tested. 2. You really don’t think the cohort of people who would refuse testing wouldn’t also be less likely to follow CDC guidelines? This increasing the chance they are infected. 3. All I was trying to say, was that random testing will be confounded by things like people refusing. Perhaps it gets us close enough. Perhaps people who refuse are more likely to be infected. Or maybe less likely, because they are loners who don’t go out thanks to their doomsday prepping or something. I think it is worth being aware of.
You seem to be incredibly confident that the cohort who would refuse testing will have the exact same infection rate as everyone else. Care to share why you are so certain of that?
I don’t know if they’re the only ones doing random testing, but my understanding is that they were able to put pressure on the CDC when no one in the US was legally allowed to test other than the CDC. they were somehow able to circumvent testing restrictions by claiming research status since they were in the middle of a two year flu study.
In any event, I suspect the cost and difficulty of good randomized is why they needed such good funding for only a 2 year study.
South Korea (and Singapore and HK etc.) had a specific policy of contact tracing instead of random sampling, which works if you start it early enough and can actually keep ahead of suspected contact spread.
In the extreme case, if you require a ventilator right now or you'll die, nobody needs to wait on verification of the specific viral cause to begin treatment.
It is not low value for the healthcare providers, though, who can spare measures against getting infected to those who actually have COVID and thus both save time and scarce resources.
To the best of my knowledge this isn't true. Only specific product lines by specific manufacturers are approved for clinical use by most governments. As far as I know, the reagents used for RNA extraction and PCR are cheap and readily available.